Atherosclerotic cardiovascular disease in systemic lupus erythematosus: the Beer Sheva experience

Mahmoud Abu-Shakra1, Shlomi Codish, Lior Zeller

  • 1Rheumatic Diseases Unit and Lupus Clinic, Soroka Medical Center, Beer Sheva, Israel. mahmoud@bgu.ac.il

Insights

Systemic lupus erythematosus (SLE) patients face high risks of atherosclerotic disease due to traditional and SLE-specific factors. Endothelial dysfunction and arterial stiffness are key contributors, necessitating further research into diagnostic methods.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Immunology

Background:

  • Atherosclerotic disease is highly prevalent in patients with systemic lupus erythematosus (SLE).
  • Pathogenesis involves traditional cardiovascular risk factors alongside SLE-specific mechanisms.
  • Endothelial dysfunction and arterial stiffness are significant contributors to atherosclerosis in SLE.

Purpose of the Study:

  • To investigate the role of endothelial dysfunction and arterial stiffness in SLE-related atherosclerosis.
  • To evaluate the utility of dobutamine stress echocardiogram in detecting subclinical coronary artery disease in SLE patients.
  • To assess the significance of left ventricular outflow gradient in this population.

Main Methods:

  • Review of existing literature on atherosclerosis in SLE.
  • Analysis of factors contributing to endothelial dysfunction and arterial stiffness.
  • Evaluation of dobutamine stress echocardiogram findings in SLE patients.

Main Results:

  • Dobutamine stress echocardiogram has not demonstrated efficacy in detecting subclinical coronary artery disease in SLE.
  • A high percentage of left ventricular outflow gradient was observed, warranting further investigation.

Conclusions:

  • Atherosclerosis in SLE is multifactorial, involving both traditional and disease-specific elements.
  • Endothelial dysfunction and arterial stiffness are critical components of the atherogenic process in SLE.
  • The role of left ventricular outflow gradient requires additional research and follow-up studies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...